All Stories

  1. Control of cellular cortical tension and shape by RhoGTPase signalling
  2. CDK12 inhibition reveals melanoma dependence on the RUNX1/CBFβ complex for genomic stability
  3. mTOR inhibition reprograms cellular lipid homeostasis by inducing alternative lipid uptake and promoting cholesterol transport
  4. A platform for the systematic interrogation of genetic interactions in human cells: 26 gene by genome-wide double knockout screens as a proof of concept
  5. 14-3-3ζ allows for adipogenesis by modulating chromatin accessibility during the early stages of adipocyte differentiation
  6. IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia
  7. The expanding landscape of canonical and non-canonical protein phosphorylation
  8. Immunotherapeutic targeting of surfaceome heterogeneity in AML
  9. Plakoglobin regulates adipocyte differentiation independently of the Wnt/β-catenin signaling pathway
  10. 14-3-3ζ regulates adipogenesis by modulating chromatin accessibility during the early stages of adipocyte differentiation
  11. Identification of RSK substrates using an analog-sensitive kinase approach
  12. The CDK12 inhibitor SR-4835 functions as a molecular glue that promotes cyclin K degradation in melanoma
  13. The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression
  14. CBFA2T3::GLIS2 Pediatric Acute Megakaryoblastic Leukemia is Sensitive to BCL-XL Inhibition by Navitoclax and DT2216
  15. Synergistic action of actin binding proteins regulate actin network organization and cell shape
  16. Author Correction: In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer
  17. SPAT: Surface Protein Annotation Tool
  18. HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer
  19. The CDK12 inhibitor SR-4835 functions as a molecular glue that promotes cyclin K degradation in melanoma
  20. In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer
  21. Identification of Novel Antigens for Normal Karyotype Triple Mutated Acute Myeloid Leukemia
  22. Identification of Novel Cell Surface Therapeutic Targets for KMT2A-Rearranged Acute Myeloid Leukemia
  23. CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma
  24. Proteomic analysis of the actin cortex in interphase and mitosis
  25. CEACAM1 is a novel culture-compatible surface marker of expanded long-term reconstituting hematopoietic stem cells
  26. 1396-P: Critical Cellular Functions That Mediate the Early Stages of Adipogenesis Are Directly Influenced by 14-3-3zeta and Its Interactome
  27. Triglyceride-derived fatty acids reduce autophagy in a model of retinal angiomatous proliferation
  28. In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer
  29. Proteomic analysis of the actin cortex in interphase and mitosis
  30. Plakoglobin regulates adipocyte differentiation independently of the Wnt/β-catenin signalling pathway
  31. Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb
  32. RIOK2 phosphorylation by RSK promotes synthesis of the human small ribosomal subunit
  33. Transmembrane receptor DCC associates with protein synthesis machinery and regulates translation
  34. Correction: RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activation
  35. Sustained ERK1/2 signaling is necessary for follicular rupture during ovulation in mice
  36. RIOK2 phosphorylation by RSK promotes synthesis of the human small ribosomal subunit
  37. Targeting copper metabolism to defeat KRAS-driven colorectal cancer
  38. STRIPAK regulates Slik localization to control mitotic morphogenesis and epithelial integrity
  39. An ErbB2 splice variant lacking exon 16 drives lung carcinoma
  40. Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer
  41. SPIN90 associates with mDia1 and the Arp2/3 complex to regulate cortical actin organization
  42. Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling
  43. NF45 and NF90 Regulate Mitotic Gene Expression by Competing with Staufen-Mediated mRNA Decay
  44. Controversies around the function of LARP1
  45. Publisher Correction: Regulation of protein kinase Cδ Nuclear Import and Apoptosis by Mechanistic Target of Rapamycin Complex-1
  46. F-Actin Interactome Reveals Vimentin as a Key Regulator of Actin Organization and Cell Mechanics in Mitosis
  47. Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion
  48. Regulation of protein kinase Cδ Nuclear Import and Apoptosis by Mechanistic Target of Rapamycin Complex-1
  49. Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities
  50. Misshapen coordinates protrusion restriction and actomyosin contractility during collective cell migration
  51. Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia
  52. Predisposing germline mutations in high hyperdiploid acute lymphoblastic leukemia in children
  53. ERK2 regulates epithelial-to-mesenchymal plasticity through DOCK10-dependent Rac1/FoxO1 activation
  54. Nckipsd Coordinates Arp2/3 and Formin Nucleation of Actin Filaments in the Cell Cortex
  55. Genetic Landscape of Electron Transport Chain Complex I Dependency in Acute Myeloid Leukemia
  56. Coordination of Pro- and Anti-Inflammatory Signals Determine Human Hematopoietic Stem and Progenitor Cell Expansion
  57. Germline GAB2 Mutations in Childhood Acute Lymphoblastic Leukemia
  58. Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of Mitochondrial Vulnerability in Acute Myeloid Leukemia
  59. Abstract 3502: Chemoproteomics provide insights into cell surface reprogramming during KRAS-mediated transformation
  60. The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression
  61. RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma
  62. Signaling Pathways Involved in the Regulation of mRNA Translation
  63. Defining the role of the RSK isoforms in cancer
  64. CdGAP/ARHGAP31 is regulated by RSK phosphorylation and binding to 14-3-3β adaptor protein
  65. RSK (p90 Ribosomal S6 Kinase)
  66. The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade During HER2-Positive Breast Cancer Progression
  67. Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 Inhibition
  68. EPCR expression marks UM171-expanded CD34+ cord blood stem cells
  69. Actin cortex architecture regulates cell surface tension
  70. A new inhibitor of the β-arrestin/AP2 endocytic complex reveals interplay between GPCR internalization and signalling
  71. Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylate Gab2 To Promote a Negative-Feedback Loop That Attenuates Phosphoinositide 3-Kinase/Akt Signaling
  72. Targeting Pre-Leukemic Stem Cells in T-Acute Lymphoblastic Leukemia
  73. Proteomics Screen Identifies Class I Rab11 Family Interacting Proteins as Key Regulators of Cytokinesis
  74. High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells
  75. RSK (p90 Ribosomal S6 Kinase)
  76. ISDN2014_0400: Mutations in DOCK7 in individuals with epileptic encephalopathy and cortical blindness
  77. Targeting pre-leukemic stem cells in T-acute lymphoblastic leukemia
  78. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression
  79. Translational control by oncogenic signaling pathways
  80. Effect of the Transient Pharmacological Inhibition of Mapk3/1 Pathway on Ovulation in Mice
  81. The expanding role of mTOR in cancer cell growth and proliferation
  82. Regulation of global and specific mRNA translation by the mTOR signaling pathway
  83. A biosensor to monitor dynamic regulation and function of tumour suppressor PTEN in living cells
  84. Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3
  85. Cellular Control of Cortical Actin Nucleation
  86. Mechanistic target of rapamycin (MTOR) signaling during ovulation in mice
  87. Mutations in DOCK7 in Individuals with Epileptic Encephalopathy and Cortical Blindness
  88. The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation
  89. Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5′TOP mRNA translation
  90. Casein Kinase 1ϵ Promotes Cell Proliferation by Regulating mRNA Translation
  91. The Coming of Age of Phosphoproteomics—from Large Data Sets to Inference of Protein Functions
  92. Cell cortex composition and homeostasis resolved by integrating proteomics and quantitative imaging
  93. Rapamycin Resistance: mTORC1 Substrates Hold Some of the Answers
  94. Insulin Activates RSK (p90 Ribosomal S6 Kinase) to Trigger a New Negative Feedback Loop That Regulates Insulin Signaling for Glucose Metabolism
  95. Cell cycle regulation of Greatwall kinase nuclear localization facilitates mitotic progression
  96. Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly
  97. Glycogen synthase kinase-3β positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1
  98. Abstract 5191: Gab2 phosphorylation by RSK inhibits Shp2 recruitment and cell motility.
  99. Gab2 Phosphorylation by RSK Inhibits Shp2 Recruitment and Cell Motility
  100. RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance
  101. RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activation
  102. Phosphorylation of the Eukaryotic Translation Initiation Factor 4E-Transporter (4E-T) by c-Jun N-Terminal Kinase Promotes Stress-Dependent P-Body Assembly
  103. Regulation of mRNA Translation by Signaling Pathways
  104. RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth
  105. F-Box Proteins Elongate Translation During Stress Recovery
  106. Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
  107. Regulation of Karyopherin α1 and Nuclear Import by Mammalian Target of Rapamycin
  108. Regulation and function of the RSK family of protein kinases
  109. RSK (p90 Ribosomal S6 Kinase)
  110. Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
  111. A comprehensive map of the mTOR signaling network
  112. mTOR, la cible fonctionnelle de la rapamycine
  113. ERK1/2 Phosphorylate Raptor to Promote Ras-dependent Activation of mTOR Complex 1 (mTORC1)
  114. mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide
  115. Paving the way for targeting RSK in cancer
  116. Transmembrane Receptor DCC Associates with Protein Synthesis Machinery and Regulates Translation
  117. mTORC1-Activated S6K1 Phosphorylates Rictor on Threonine 1135 and Regulates mTORC2 Signaling
  118. Regulation of mTOR Complex 1 (mTORC1) by Raptor Ser 863 and Multisite Phosphorylation
  119. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
  120. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation
  121. Oncogenic MAPK Signaling Stimulates mTORC1 Activity by Promoting RSK-Mediated Raptor Phosphorylation
  122. The RSK factors of activating the Ras/MAPK signaling cascade
  123. Rsk4
  124. Rsk3
  125. Rsk1
  126. RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation
  127. Mind the GAP: Wnt Steps onto the mTORC1 Train
  128. The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity
  129. The Tumor Suppressor DAP Kinase Is a Target of RSK-Mediated Survival Signaling
  130. Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors
  131. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase
  132. ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions
  133. Protein Kinase A Activation Promotes Plasma Membrane Insertion of DCC from an Intracellular Pool: A Novel Mechanism Regulating Commissural Axon Extension
  134. Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb
  135. Phosphorylation of p90 Ribosomal S6 Kinase (RSK) Regulates Extracellular Signal-Regulated Kinase Docking and RSK Activity
  136. K252a and CEP1347 Are Neuroprotective Compounds That Inhibit Mixed-lineage Kinase-3 and Induce Activation of Akt and ERK
  137. Neurotrophin signaling through the p75 neurotrophin receptor
  138. The p75 Neurotrophin Receptor Activates Akt (Protein Kinase B) through a Phosphatidylinositol 3-Kinase-dependent Pathway
  139. NRAGE, A Novel MAGE Protein, Interacts with the p75 Neurotrophin Receptor and Facilitates Nerve Growth Factor–Dependent Apoptosis
  140. Activation of Transcription Factors NF-κB and NF-IL-6 by Human Immunodeficiency Virus Type 1 Protein R (Vpr) Induces Interleukin-8 Expression
  141. p75 Neurotrophin Receptor Expression Is Induced in Apoptotic Neurons After Seizure
  142. The p75 Neurotrophin Receptor (p75NTR) Alters Tumor Necrosis Factor-mediated NF- B Activity under Physiological Conditions, but Direct p75NTR-mediated NF- B Activation Requires Cell Stress
  143. INCREASED APOPTOSIS, CHANGES IN INTRACELLULAR Ca2+, AND FUNCTIONAL ALTERATIONS IN LYMPHOCYTES AND MACROPHAGES AFTER IN VITRO EXPOSURE TO STATIC MAGNETIC FIELD
  144. MAPK Signaling in Human Diseases